Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders
US9163049B2 · kind B2 · utility
0Cited by
3References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 14, 2009 |
| Grant date | Oct 20, 2015 |
| Priority date | — |
| Expiry date | Oct 15, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a medicament comprising at least one reducing alkyl-sugar monomer having a hydroxyl function which is substituted by an alkoxy radical at C2-C40, said medicament being preferably intended to regulate inflammatory mechanisms. The reducing sugar is preferably selected from the group containing rhamnose, fucose and glucose. The invention also relates to a cosmetic treatment method involving the topical application of a composition comprising at least one reducing alkyl-sugar monomer having a hydroxyl function which is substituted by an alkoxy radical at C2-C40.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.